ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples